Uteroplacental blood flow in pregnancy hypertension after the administration of a beta-adrenoceptor blocker, pindolol. 1984

N O Lunell, and L Nylund, and R Lewander, and B Sarby, and J Wager

The effect of a beta-adrenoceptor blocker, pindolol, on uteroplacental blood flow was determined in 10 women with pregnancy hypertension using an isotope technique giving a very low radiation dose. 0.5 mCi 113mIn was injected intravenously before and 30 min after 10 mg pindolol was given orally. After the administrations of 113mIn serial scintigrams were recorded for 240 s by a gamma camera on line with a computer, and the placenta was outlined for time-activity analysis of the isotope accumulation curves. From these curves a relative measure of the uteroplacental blood flow could be determined. Pindolol induced a significant fall in mean arterial pressure but there was no reduction of uteroplacental blood flow index.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D010869 Pindolol A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638) Prindolol,LB-46,Visken,LB 46,LB46
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic

Related Publications

N O Lunell, and L Nylund, and R Lewander, and B Sarby, and J Wager
June 1979, The British journal of clinical practice,
N O Lunell, and L Nylund, and R Lewander, and B Sarby, and J Wager
January 1988, Acta Universitatis Palackianae Olomucensis Facultatis Medicae,
N O Lunell, and L Nylund, and R Lewander, and B Sarby, and J Wager
June 1995, Zhonghua fu chan ke za zhi,
N O Lunell, and L Nylund, and R Lewander, and B Sarby, and J Wager
August 1994, Journal of applied physiology (Bethesda, Md. : 1985),
N O Lunell, and L Nylund, and R Lewander, and B Sarby, and J Wager
November 2000, Pain,
N O Lunell, and L Nylund, and R Lewander, and B Sarby, and J Wager
December 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
N O Lunell, and L Nylund, and R Lewander, and B Sarby, and J Wager
May 1989, Human pathology,
N O Lunell, and L Nylund, and R Lewander, and B Sarby, and J Wager
September 1981, British journal of clinical pharmacology,
N O Lunell, and L Nylund, and R Lewander, and B Sarby, and J Wager
February 1978, The New Zealand medical journal,
N O Lunell, and L Nylund, and R Lewander, and B Sarby, and J Wager
August 1980, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!